| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
| mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
0.9 |
| mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
1 |